Week in Review: January 20–24

Mistimed sleep disrupts human transcriptome; canine tumor genome; de novo Drosophila genes; UVA light lowers blood pressure; aquatic microfauna fight frog-killing fungus

Written byTracy Vence
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, JULIE VACCALLUZZOA mistimed sleep cycle drastically reduces the number of genes that are expressed in a 24-hour rhythm, scientists reported in PNAS this week (January 20). Most of those genes are involved in transcription and translation, the authors noted.

“The shifting the time of sleep has enormous consequences,” said neurobehavioral geneticist Valter Tucci at the Italian Institute of Technology in Genova, who was not involved in the study. “It’s not by chance that evolution has favored the development of sleep at a particular time,” he added.

WIKIPEDIA, SCMWResearchers reported genome sequences for two canine transmissible venereal tumors in Science this week (January 23), noting that the cancer has picked up around 1.9 million mutations over the last 11,000 or so years. The University of Sydney’s Katherine Belov, who was not involved in the work, pointed out similarities between this transmissible dog cancer and devil facial tumor disease, which continues to ravage Tasmanian devil populations.

“I think it is really important that we continue to study these contagious cancers,” Belov told The Scientist. “They have evolved at least twice. What allows these cancers to emerge, and to become successful and immortal? If we can answer these questions, we will gain insights into human cancers too.”

WIKIMEDIA, MUHAMMAD MAHDI KARIMScanning the transcriptomes of several Drosophila strains, researchers uncovered dozens of possible de novo genes in each. Presented in Science this week (January 23), the research supports the notion that de novo gene formation may even be a common phenomenon.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies